Jolly Jasleen K, Xue Kanmin, Edwards Thomas L, Groppe Markus, MacLaren Robert E
Nuffield Laboratory of Ophthalmology, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.
Oxford Eye Hospital, John Radcliffe Hospital, Oxford, United Kingdom.
Invest Ophthalmol Vis Sci. 2017 Oct 1;58(12):5575-5583. doi: 10.1167/iovs.17-22486.
Centripetal retinal degeneration in choroideremia (CHM) leads to early visual field restriction and late central vision loss. The latter marks an acute decline in quality of life but visual prognostication remains challenging. We investigated visual function in CHM by correlating best-corrected visual acuity (BCVA), microperimetry and multimodal imaging.
Fifty-six consecutive CHM patients attending Oxford Eye Hospital were examined with BCVA, 10-2 microperimetry, optical coherence tomography, and fundus autofluorescence (AF). Microperimetry was repeated in 21 eyes and analyzed with Bland-Altman. Kaplan-Meier survival plots of eyes retaining 20/20 BCVA were created. Intereye symmetry was assessed.
Microperimetry coefficient of repeatability was 1.45 dB. Survival analysis showed an indistinguishable pattern between eyes (median survival 39 years). Macular sensitivity showed a similar decline in right and left eyes, with half-lives of 13.6 years. Zonal analysis showed faster decline nasal to the fovea. Intereye symmetry was more consistent for microperimetry sensitivity (r = 0.95, P < 0.001) than BCVA (r = 0.42, P = 0.0006). Near normal foveal sensitivity was maintained when the fovea was at least 2500 μm from the advancing edge of AF.
BCVA is a marker of central degeneration and can provide valuable information about the position of the remaining retina as well as a measure of the impact on daily living. Microperimetry represents the global macular region. Both visual functions showed a high degree of intereye symmetry, particularly in early stages, indicating the fellow eye can provide a suitable control for assessing interventions to one eye. The findings may help to tailor visual prognosis and interpret outcomes of trials.
脉络膜视网膜病变(CHM)中的向心性视网膜变性会导致早期视野受限和晚期中心视力丧失。后者标志着生活质量急剧下降,但视力预后仍然具有挑战性。我们通过将最佳矫正视力(BCVA)、微视野检查和多模态成像相关联,研究了CHM患者的视觉功能。
对连续就诊于牛津眼科医院的56例CHM患者进行了BCVA、10-2微视野检查、光学相干断层扫描和眼底自发荧光(AF)检查。对21只眼重复进行微视野检查,并采用布兰德-奥特曼法进行分析。绘制了保持20/20 BCVA的眼睛的Kaplan-Meier生存曲线。评估双眼对称性。
微视野检查的重复性系数为1.45 dB。生存分析显示两眼之间的模式无明显差异(中位生存期39年)。黄斑敏感度在右眼和左眼显示出相似的下降,半衰期为13.6年。分区分析显示,黄斑中心凹鼻侧的下降速度更快。微视野检查敏感度的双眼对称性(r = 0.95,P < 0.001)比BCVA(r = 0.42,P = 0.0006)更一致。当黄斑中心凹距离AF进展边缘至少2500μm时,可维持接近正常的黄斑中心凹敏感度。
BCVA是中心性变性的一个指标,可提供有关剩余视网膜位置的有价值信息以及对日常生活影响的衡量标准。微视野检查代表整个黄斑区域。两种视觉功能均显示出高度的双眼对称性,尤其是在早期阶段,这表明对侧眼可为评估单眼干预措施提供合适的对照。这些发现可能有助于调整视力预后并解释试验结果。